Cullen/Frost Bankers, Inc. Ionis Pharmaceuticals Inc Transaction History

Cullen/Frost Bankers, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 05, 2021	SELL	$42.51 - $63.78 $7,141 - $10,715	-168 Closed	0 $0
Q3 2020 Nov 05, 2020	SELL	$47.45 - $62.95 $40,047 - $53,129	-844 Reduced 83.4%	168 $8,000
Q2 2020 Aug 05, 2020	BUY	$46.85 - $61.05 $37,480 - $48,840	800 Added 377.36%	1,012 $60,000
Q1 2020 May 01, 2020	SELL	$41.6 - $63.4 $1,830 - $2,789	-44 Reduced 17.19%	212 $10,000
Q4 2019 Feb 06, 2020	SELL	$53.85 - $65.27 $53 - $65	-1 Reduced 0.39%	256 $15,000
Q3 2019 Nov 01, 2019	SELL	$59.06 - $72.15 $63,784 - $77,922	-1,080 Reduced 80.78%	257 $15,000
Q2 2019 Aug 01, 2019	BUY	$62.09 - $86.14 $5,526 - $7,666	89 Added 7.13%	1,337 $86,000
Q1 2019 Apr 30, 2019	BUY	$52.92 - $81.17 $66,044 - $101,300	1,248 New	1,248 $101,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.